Faculty who have authored publication Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
| Name | Title | Department | Institution |
|---|---|---|---|
| Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |
